Patino-Salazar J, Ovejero D, Gabernet M, Martinez-Gil N, Alcaide-Consuegra E, Mellibovsky L
Osteoporos Int. 2025; .
PMID: 39915337
DOI: 10.1007/s00198-025-07413-4.
Kang H, Peng R, Dong Y, Dong Y, Liao F, Zhu M
Mol Ther. 2025; 33(3):933-949.
PMID: 39863932
PMC: 11897774.
DOI: 10.1016/j.ymthe.2025.01.040.
Niu Z, Xia X, Zhang Z, Liu J, Li X
Int J Nanomedicine. 2025; 20:161-179.
PMID: 39802379
PMC: 11721695.
DOI: 10.2147/IJN.S389156.
Hao G, Han S, Xiao Z, Shen J, Zhao Y, Hao Q
Heliyon. 2024; 10(24):e41003.
PMID: 39720069
PMC: 11665477.
DOI: 10.1016/j.heliyon.2024.e41003.
Ma D, Zhu Z, Tan X, Lin Q, Huang Y, Mao M
J Cell Mol Med. 2024; 28(23):e70223.
PMID: 39622788
PMC: 11611524.
DOI: 10.1111/jcmm.70223.
Molecular mechanism of bone metastasis in breast cancer.
Sui L, Wang J, Jiang W, Song X, Ye L
Front Oncol. 2024; 14:1401113.
PMID: 39605887
PMC: 11599183.
DOI: 10.3389/fonc.2024.1401113.
Unveiling the Link Between Breast Cancer Treatment and Osteoporosis: Implications for Anticancer Therapy and Bone Health.
Goel B, Virmani T, Jain V, Kumar G, Sharma A, Al Noman A
Biomed Res Int. 2024; 2024:5594542.
PMID: 39574432
PMC: 11581800.
DOI: 10.1155/2024/5594542.
Irisin reduces senile osteoporosis by inducing osteocyte mitophagy through Ampk activation.
Li H, Luo D, Xie W, Ye W, Chen J, Alberton P
iScience. 2024; 27(11):111042.
PMID: 39559753
PMC: 11570468.
DOI: 10.1016/j.isci.2024.111042.
Cell-cell fusion: To lose one life and begin another.
Whitlock J, Chernomordik L
Bioessays. 2024; 47(2):e2400206.
PMID: 39506368
PMC: 11755699.
DOI: 10.1002/bies.202400206.
Bone-Targeted Fluoropeptide Nanoparticle Inhibits NF-κB Signaling to Treat Osteosarcoma and Tumor-Induced Bone Destruction.
Li L, Rong G, Gao X, Cheng Y, Sun Z, Cai X
Adv Sci (Weinh). 2024; 12(1):e2412014.
PMID: 39501934
PMC: 11714165.
DOI: 10.1002/advs.202412014.
From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches.
Li Q, Wang J, Zhao C
Biomedicines. 2024; 12(10).
PMID: 39457701
PMC: 11505085.
DOI: 10.3390/biomedicines12102389.
Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect.
El-Masri B, Andreasen C, Laursen K, Kofod V, Dahl X, Nielsen M
Bone Res. 2024; 12(1):62.
PMID: 39424806
PMC: 11489716.
DOI: 10.1038/s41413-024-00362-4.
Optimized intravital three-photon imaging of intact mouse tibia links plasma cell motility to functional states.
Rakhymzhan A, Fiedler A, Gunther R, Domingue S, Wooldridge L, Leben R
iScience. 2024; 27(10):110985.
PMID: 39391739
PMC: 11466647.
DOI: 10.1016/j.isci.2024.110985.
Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway.
Dong H, Liu X, Duan J, Zhang J, Liu H, Shen T
Aging (Albany NY). 2024; 16(17):12263-12276.
PMID: 39197167
PMC: 11424582.
DOI: 10.18632/aging.206084.
The therapeutic mechanism of Compound Lurong Jiangu Capsule for the treatment of cadmium-induced osteoporosis: network pharmacology and experimental verification.
Zhou Y, Huang J, Cao W, Yu A, Li P, Liang J
Front Endocrinol (Lausanne). 2024; 15:1331488.
PMID: 39050570
PMC: 11266182.
DOI: 10.3389/fendo.2024.1331488.
Osteostaticytes: A novel osteoclast subset couples bone resorption and bone formation.
Wei Z, Zhou J, Shen J, Sun D, Gao T, Liu Q
J Orthop Translat. 2024; 47:144-160.
PMID: 39027343
PMC: 11254843.
DOI: 10.1016/j.jot.2024.06.010.
Osteoporotic osseointegration: therapeutic hallmarks and engineering strategies.
Chen J, Hao Z, Li H, Wang J, Chen T, Wang Y
Theranostics. 2024; 14(10):3859-3899.
PMID: 38994021
PMC: 11234277.
DOI: 10.7150/thno.96516.
A Microenvironment-Responsive, Controlled Release Hydrogel Delivering Embelin to Promote Bone Repair of Periodontitis via Anti-Infection and Osteo-Immune Modulation.
Cai G, Ren L, Yu J, Jiang S, Liu G, Wu S
Adv Sci (Weinh). 2024; 11(34):e2403786.
PMID: 38978324
PMC: 11425865.
DOI: 10.1002/advs.202403786.
Efferocytosis and Bone Dynamics.
Batoon L, Hawse J, McCauley L, Weivoda M, Roca H
Curr Osteoporos Rep. 2024; 22(5):471-482.
PMID: 38914730
DOI: 10.1007/s11914-024-00878-y.
diABZI and poly(I:C) inhibit osteoclastic bone resorption by inducing IRF7 and IFIT3.
Huang Y, Zhang M, Zhang J, Liu S, Li D, Qiao Z
J Bone Miner Res. 2024; 39(8):1132-1146.
PMID: 38874138
PMC: 11337579.
DOI: 10.1093/jbmr/zjae093.